#192 Debate on First-Line Medications for Diabetes

SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use? 🔹 Sponsor: Use the code "CORE30" for 30% off: 🔹 Transcript and Show Notes Timestamps: (01:43) | Case 1: Managing Uncontrolled Diabetes in a 47-Year-Old Male (07:15) | Understanding Cost and Insurance Barriers in Diabetes Care (09:26) | Case 2: Addressing Weight Gain and Financial Stress in a 52-Year-Old Male (14:16) | Case 3: Managing Coronary Artery Disease and CKD in a 66-Year-Old Male (19:41) | Case 4: Severe Obesity and Pain Management in a 59-Year-Old Female (24:19) | Case 5: High A1C and Vascular Comorbidities in a 67-Year-Old Female (35:34) | Weighing Side Effects and Practical Use of GLP-1 and SGLT2 Inhibitors Tags: CoreIM, Primary Care, Endocrinology, Diabetes Mellitus, Type 2 Diabetes, Type 1 Diabetes, Metformin, GLP-1, SGLT2, Insulin, CGM, A1C, DKA, Medical Education, Clinical Reasoning, Hospital Medicine Find the best disability insurance for you: Our Sponsors: * Check out FIGS: * Click for 15% off Premium Starter Kit at Branch Basics: Advertising Inquiries: Privacy & Opt-Out:

You can listen to #192 Debate on First-Line Medications for Diabetes online on Radio and Podcast. Open the player on this page to stream the available audio.

#192 Debate on First-Line Medications for Diabetes is an episode from Core IM | Internal Medicine Podcast by Core IM Team.

This episode is 36:50 long.

This episode was published on Nov 5, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Core IM | Internal Medicine Podcast when more episodes are available from the podcast feed.